Selected infectious agents and risk of schizophrenia among U.S. military personnel

American Journal of Psychiatry

Volumn 165, Issue 1, 2008, Pages 99-106

  Niebuhr, David W ^a   Millikan, Amy M ^b   Cowan, David N ^b   Yolken, Robert ^b   Li, Yuanzhang ^b   Weber, Natalya S ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; HERPES VIRUS; HOSPITALIZATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SOLDIER; TOXOPLASMA GONDII; UNITED STATES; ADOLESCENT; ANIMAL; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; RISK FACTOR; STATISTICS; TOXOPLASMA; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; FEMALE; HERPESVIRIDAE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; MALE; MILITARY PERSONNEL; RISK FACTORS; SCHIZOPHRENIA; TOXOPLASMA; TOXOPLASMOSIS; UNITED STATES;

EID: 39049159643     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.06081254     Document Type: Article

References (41)

1. Rice DP: The economic impact of schizophrenia. J Clin Psychiatry 1999; 60(suppl 1):4-6
2. Yolken RH, Torrey EF: Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995; 8:131-145
3. Torrey EF: Epidemiological comparison of schizophrenia and bipolar disorder. Schizophr Res 1999; 39:101-106 discussion 159-160
4. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH: Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 2001; 58:1032-1037
5. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH: Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry 2003; 60:466-472
6. Hinze-Selch D: Infection, treatment and immune response in patients with bipolar disorder versus patients with major depression, schizophrenia or healthy controls. Bipolar Disord 2002; 4:81-83
7. Prasad KM, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL: Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Mol Psychiatry 2007; 12:105-113
8. Selten JP, Kahn RS: Schizophrenia after prenatal exposure to toxoplasma gondii? Clin Infect Dis 2002; 35:633-634
9. Torrey EF, Yolken RH, Winfrey CJ: Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. Science 1982; 216:892-894
10. Kramer W: Frontiers of neurological diagnosis in acquired toxoplasmosis. Psychiatr Neurol Neurochir 1966; 69:43-64
11. Witting PA: Learning capacity and memory of normal and toxoplasma-infected laboratory rats and mice. Z Parasitenkd 1979; 61:29-51
12. Tenter AM, Heckeroth AR, Weiss LM: Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30:1217-1258
13. Torrey EF, Yolken RH: Toxoplasma gondii and schizophrenia. Emerg Infect Dis 2003; 9:1375-1380
14. Torrey EF, Bartko JJ, Lun ZR, Yolken RH: Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 2007; 33:729-736. Epub 2006 Nov 3
15. Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, Schroeder J: Antibodies to toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis 2001; 32:842-844
16. Alvarado-Esquivel C, Alanis-Quinones OP, Arreola-Valenzuela MA, Rodriguez-Briones A, Piedra-Nevarez LJ, Duran-Morales E, Estrada-Martinez S, Martinez-Garcia SA, Liesenfeld O: Seroepidemiology of toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis 2006; 6:178
17. Leweke FM, Gerth CW, Koethe D, Klosterkotter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH: Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254:4-8
18. Rubertone MV, Brundage JF: The defense medical surveillance system and the department of defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 2002; 92:1900-1904
19. U.S. Department of Defense: Army Medical Surveillance Activity. Aberdeen Proving Ground, Md, USACHPPM. http://amsa.army.mil/AMSA/amsa_home.htm (accessed May 2007)
20. Focus Diagnostics: HSV-1 and HSV-2. Cypress, Calif, Focus Diagnostics. www.focusdx.com (accessed April 2007)
21. Advance Biotechnologies: HHV-6: Columbia, Md, Advanced Biotechnologies, Inc. http://www.abionline.com/products/diagnostic/specs/15302.htm (accessed April 2007)
22. IBL-America: EBV and VZV. Minneapolis, Minn, Immuno-Biological Laboratories, Inc. www.ibl-america.com (accessed April 2007)
23. Viro-Immun Labor-Diagnostika: Toxoplasma and CMV. Oberursel, Germany, Viro-Immun Labor-Diagnostika GmbH, 2006. http://www.viro-immun.de/pdf/ Product%20price%20catalog%20February%202006.pdf (accessed April 2007)
24. Amminger GP, McGorry PD, Berger GE, Wade D, Yung AR, Phillips LJ, Harrigan SM, Francey SM, Yolken RH: Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry 2007; 61:1119-1120
25. Dubey JR, Fair PA, Bossartt GD, Hill D, Fayer R, Sreekumar C, Kwok OC, Thulliez P: A comparison of several serologic tests to detect antibodies to toxoplasma gondii in naturally exposed bottlenose dolphins (Tursiops truncatus). J Parasitol 2005; 91:1074-1081
26. Petithory JC, Reiter-Owona I, Berthelot F, Milgram M, De Loye J, Petersen E: Performance of European laboratories testing serum samples for toxoplasma gondii. Eur J Clin Microbiol Infect Dis 1996; 15:45-49
27. Wit E, McClure JD: Statistics for Microarrays Design, Analysis, and Inference. New York, Wiley, 2004
28. Hosmer DW, Lemeshow S: Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, Wiley, 1999
29. Katz MH: Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003; 138:644-650
30. Hoge CW, Lesikar SE, Guevara R, Lange J, Brundage JF, Engel CC Jr, Messer SC, Orman DT: Mental disorders among U.S. military personnel in the 1990s: association with high levels of health care utilization and early military attrition. Am J Psychiatry 2002; 159:1576-1583
31. Millikan AM, Weber NS, Niebuhr DW, Torrey EF, Cowan DN, Li Y, Kaminski B: Evaluation of data obtained from military disability medical administrative databases for service members with schizophrenia or bipolar disorder. Mil Med 2007; 172:1032-1038
32. Schwarz MJ, Kronig H, Riedel M, Dehning S, Douhet A, Spellmann I, Ackenheil M, Moller HJ, Muller N: IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2006; 256:72-76
33. Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES: Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162:767-773
34. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB: Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154:357-365
35. Suzuki Y: Host resistance in the brain against Toxoplasma gondii. J Infect Dis 2002; 185(suppl 1):S58-65
36. Sergent V, Cautain B, Khalife J, Deslee D, Bastien P, Dao A, Dubremetz JF, Fournie GJ, Saoudi A, Cesbron-Delauw MF: Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells. Infect Immun 2005; 73:6990-6997
37. Saeij JP, Boyle JP, Grigg ME, Arrizabalaga G, Boothroyd JC: Bioluminescence imaging of toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect Immun 2005; 73:695-702
38. Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF, Yolken RH: Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007; 61:688-693
39. Berdoy M, Webster JP, Macdonald DW: Fatal attraction in rats infected with toxoplasma gondii. Proc Biol Sci 2000; 267:1591-1594
40. Novotna M, Hanusova J, Klose J, Preiss M, Havlicek J, Roubalova K, Flegr J: Probable neuroimmunological link between toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infect Dis 2005; 5:54
41. McAllister MM: A decade of discoveries in veterinary protozoology changes our concept of "subclinical" toxoplasmosis. Vet Parasitol 2005; 132:241-247